These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16738034)
21. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study. Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023 [TBL] [Abstract][Full Text] [Related]
22. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197 [TBL] [Abstract][Full Text] [Related]
23. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451 [TBL] [Abstract][Full Text] [Related]
24. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation]. Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V; Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062 [TBL] [Abstract][Full Text] [Related]
25. Systemic inflammation in patients with COPD and pulmonary hypertension. Joppa P; Petrasova D; Stancak B; Tkacova R Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829 [TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959 [TBL] [Abstract][Full Text] [Related]
28. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease. Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834 [TBL] [Abstract][Full Text] [Related]
29. Myocardial perfusion reserve is impaired in patients with chronic obstructive pulmonary disease: a comparison to current smokers. Nakamori S; Onishi K; Ishida M; Nakajima H; Yamada T; Nagata M; Kitagawa K; Dohi K; Nakamura M; Sakuma H; Ito M Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):180-8. PubMed ID: 23839654 [TBL] [Abstract][Full Text] [Related]
30. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention. Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361 [TBL] [Abstract][Full Text] [Related]
31. [Causes of chronic obstructive pulmonary disease-related death and influencing factors of survival time]. Chang C; Yao WZ; Fang TS Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):824-7. PubMed ID: 21600162 [TBL] [Abstract][Full Text] [Related]
32. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Liu SF; Wang CC; Chin CH; Chen YC; Lin MC Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335 [TBL] [Abstract][Full Text] [Related]
33. The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)--a review. Lee PN Regul Toxicol Pharmacol; 2013 Dec; 67(3):372-81. PubMed ID: 24013038 [TBL] [Abstract][Full Text] [Related]
34. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Sin DD; Lacy P; York E; Man SF Am J Respir Crit Care Med; 2004 Oct; 170(7):760-5. PubMed ID: 15229100 [TBL] [Abstract][Full Text] [Related]
35. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. Lyngbæk S; Marott JL; Sehestedt T; Hansen TW; Olsen MH; Andersen O; Linneberg A; Haugaard SB; Eugen-Olsen J; Hansen PR; Jeppesen J Int J Cardiol; 2013 Sep; 167(6):2904-11. PubMed ID: 22909410 [TBL] [Abstract][Full Text] [Related]
37. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Moy ML; Teylan M; Danilack VA; Gagnon DR; Garshick E Ann Am Thorac Soc; 2014 Feb; 11(2):149-57. PubMed ID: 24308588 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Prescott E; Almdal T; Mikkelsen KL; Tofteng CL; Vestbo J; Lange P Eur Respir J; 2002 Sep; 20(3):539-44. PubMed ID: 12358326 [TBL] [Abstract][Full Text] [Related]
39. The relationship between Helicobacter pylori seropositivity and COPD. Sze MA; Chen YW; Tam S; Tashkin D; Wise RA; Connett JE; Man SP; Sin DD Thorax; 2015 Oct; 70(10):923-9. PubMed ID: 26024688 [TBL] [Abstract][Full Text] [Related]